Physicochemical Characterization of the Oral Biotherapeutic Drug IMUNOR^®

• Autori principali: Jitka Mucksová (Autore), Gabriela Borošová (Autore), Miloš Blazsek (Autore), Jiří Kalina (Autore), Lucie Minaříková (Autore), Zdeňka Svobodová (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

IMUNOR is an oral biotherapeutic drug that had been developed, registered, and approved in 1997 in the Czech Republic and Slovakia. IMUNOR is a dialyzable leukocyte extract (DLE) prepared from swine leukocytes. It is characterized as a mixture of small peptides with molecular weights smaller than 12...